MK
MJ Kuiper
Commonwealth Scientific and Industrial Research Organisation, Melbourne Bioinformatics, Swinburne University of Technology, Monash University, Victorian Partnership of Advanced Computing
Research areas: Biochemistry, Genetics and Molecular Biology · Molecular Biology · Protein Structure and Dynamics · nanoparticles nucleation surface interactions · Enzyme Structure and Function
0000-0002-8213-8382
Employment
-
Data 61 / Commonwealth Scientific and Industrial Research Organisation Bio-molecular Modeller2017 - Present
-
Victorian Life Sciences Computation Initiative Computational modeller2012 - 2017
-
Victorian Partnership of Advanced Computing Computational Scientist.2003 - 2012
-
Queens university PostDoc1998 - 2003
Education
- 1993 - 1997
-
Monash University B.Sc1987 - 1989
Projects & Funding
Projects & funding information is unavailable.
Publications (24)
- CAPBUILD: A CLOUD-NATIVE TOOL FOR ADENO-ASSOCIATED VIRUS CAPSID ENGINEERING Save
- Predictive and Generative AI for Drug Discovery: Identification of SARS-CoV2 NSP14 Inhibitors Save
- Predictive and Generative Chemistry: AI for Drug Design at CSIRO Save
- PREDICTIVE AND GENERATIVE CHEMISTRY: AI FOR DRUG DESIGN AT CSIRO Save
- N-Sulfonylphenoxazines as neuronal calcium ion channel blockers Save
- Data-Driven Analysis of Pathogen Genomes Save
- Data-driven analysis of pathogen genomes Save
- Identifying higher-order interactions associated with COVID-19 outcome using a machine learning pipeline Save
- Co-occurrence of N501Y, P681R and other key mutations in SARS-CoV-2 Spike Save
- Evidence of epistatic interactions in SARS-CoV-2 genomes correlating with host disease outcome Save
- Surveillance of key SARS-CoV-2 spike mutations: A case study of the 681R-501Y cooccurrence Save
- Cooccurrence of N501Y, P681R and other key mutations in SARS-CoV-2 Spike Save
- Detecting genomic variations in SARS-CoV-2 virus associated with disease outcome Save
- Data-driven platform for identifying variants of interest in COVID-19 virus Save
- At Least Three Doses of Leading Vaccines Essential for Neutralisation of SARS-CoV-2 Omicron Variant Save
- Highly Thermotolerant SARS-CoV-2 Vaccine Elicits Neutralising Antibodies Against Delta and Omicron in Mice Save
- Developing a 'warm' vaccine to combat SARS-CoV-2 variants of concern and address inequity Save
- Live Virus Neutralisation of the 501Y.V1 and 501Y.V2 SARS-CoV-2 Variants following INO-4800 Vaccination of Ferrets Save
- Modelling COVID-19 Spike Protein Interactions Save
- Experimental and in silico evidence suggests vaccines are unlikely to be affected by D614G mutation in SARS-CoV-2 spike protein Save